The post-PDT tumour milieu contains abundant amounts of IL-6 and other inflammatory mediators (Gollnick et al, 2003) to which surviving cells within the treatment field do not respond directly because of PDT-induced degradation and inactivation of their membrane-bound IL-6Rα. This evidence concerns the gene IL6R and neoplasm.